VisionGate
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
17280 Woodinville Redmond Rd NE Ste 800,...Phone Number
(602) 368-2118Website
www.visiongate3d.comRevenue
$20.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About VisionGate
VisionGate is a biotechnology company specializing in the early detection of lung cancer, particularly for high-risk patients, through quick and non-intrusive testing methods. Their innovative approach utilizes 3D cellular imaging and AI-powered technology to analyze sputum samples for abnormal cells. With a portfolio of 35 patents, VisionGate aims to enhance cancer detection accuracy and improve treatment outcomes. The company is committed to raising awareness about lung cancer detection while offering resources for patients and medical professionals.Explore more
VisionGate Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VisionGate your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if VisionGate is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on VisionGate recently announced quarterly report
Check if VisionGate has recently received funding, and reach out quickly before it becomes old news!
Click to see if VisionGate had a recent Job posting/layoffs
Product Launch: Get notified when VisionGate launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
VisionGate, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at VisionGate
Funding: Get notified immidiatlly once VisionGate has new funding data
Recommended Actions
Find VP level buyers at VisionGate
Find 3 more new buyers
Compare Similar Companies to VisionGate
Compare insights from companies similar to VisionGate, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
VisionGate is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VisionGate is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VisionGate.
VisionGate financials insights
Gather financial insights about VisionGate, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2008
Private Equity
$1.8M
2010
Private Equity
$4.4M
2014
Debt
$5.3M
2017
Private Equity
$20M
Private Equity
$26.1M
2020
Debt
$150K
VisionGate Tech Stack
A closer look at the technologies used by VisionGate
VisionGate News & Media
VisionGate Announces Lung Cancer Prevention Trial Progress
Selects PCI Pharma Services as Manufacturing Partner for Oral Iloprost and Receives Initial API Shipment Selects PCI Pharma Services as Manufacturing Partner for Oral Iloprost and Receives Initial API ShipmentVisionGate, Inc. Appoints R. John Glasspool as Chief Operating and Strategy Officer and member of the Board of Directors
Seattle, WA, Oct. 11, 2018 (GLOBE NEWSWIRE) -- VisionGate, Inc., an integrated, clinical-stage, oncology pharmaceutical and diagnostics company, is pleased to announce the appointment of R. John Glasspool as its Chief Operating and Strategy Officer.VisionGate’s Cell-CT™ Platform Uses 3D Cell Morphometry and Artificial Intelligence to Detect an Immunotherapy Predictive Biomarker and Cancer-Associated Cells that have undergone Malignancy Associated Change (MAC) from Liquid Biopsy
Breakthrough Research to be Presented at the 2018 World Conference on Lung Cancer Breakthrough Research to be Presented at the 2018 World Conference on Lung CancerVisionGate Announces New Appointment to the Board of Directors
Experienced Pharma, Diagnostics and Biotech Executive Strengthens Company Leadership Experienced Pharma, Diagnostics and Biotech Executive Strengthens Company Leadership
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VisionGate
Sign Up For FreeTo access detailed company insights
VisionGate is a biotechnology company specializing in the early detection of lung cancer, particularly for high-risk patients, through quick and non-intrusive testing methods. Their innovative approach utilizes 3D cellular imaging and AI-powered technology to analyze sputum samples for abnormal cells. With a portfolio of 35 patents, VisionGate aims... Read More
